A detailed history of Northern Trust Corp transactions in Context Therapeutics Inc. stock. As of the latest transaction made, Northern Trust Corp holds 172,511 shares of CNTX stock, worth $175,961. This represents 0.0% of its overall portfolio holdings.

Number of Shares
172,511
Previous 174,497 1.14%
Holding current value
$175,961
Previous $348,000 2.87%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$1.79 - $2.66 $3,554 - $5,282
-1,986 Reduced 1.14%
172,511 $338,000
Q2 2024

Aug 14, 2024

BUY
$1.24 - $2.19 $170,224 - $300,638
137,278 Added 368.84%
174,497 $348,000
Q4 2022

Feb 13, 2023

BUY
$0.61 - $1.42 $8,551 - $19,906
14,019 Added 60.43%
37,219 $24,000
Q2 2022

Aug 12, 2022

BUY
$1.29 - $2.66 $29,928 - $61,712
23,200 New
23,200 $49,000

Others Institutions Holding CNTX

About Context Therapeutics Inc.


  • Ticker CNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 15,966,100
  • Market Cap $16.3M
  • Description
  • Context Therapeutics Inc., a clinical-stage biopharmaceutical company, develops products for the treatment of cancer for women in the United States. Its lead product candidate is onapristone extended release (ONA-XR), a potent and selective antagonist of the progesterone receptor that is linked to resistance for various classes of cancer therape...
More about CNTX
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.